Nugene International Stock Fundamentals
| NUGN Stock | USD 0.01 0.0001 2.04% |
NuGene International fundamentals help investors to digest information that contributes to NuGene International's financial success or failures. It also enables traders to predict the movement of NuGene Pink Sheet. The fundamental analysis module provides a way to measure NuGene International's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NuGene International pink sheet.
NuGene |
NuGene International Company Return On Asset Analysis
NuGene International's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current NuGene International Return On Asset | -9.44 |
Most of NuGene International's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NuGene International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, NuGene International has a Return On Asset of -9.4427. This is much higher than that of the Financial Services sector and significantly lower than that of the Shell Companies industry. The return on asset for all United States stocks is notably higher than that of the company.
NuGene International Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NuGene International's current stock value. Our valuation model uses many indicators to compare NuGene International value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NuGene International competition to find correlations between indicators driving NuGene International's intrinsic value. More Info.NuGene International is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in profit margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NuGene International by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NuGene International's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.NuGene Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NuGene International's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of NuGene International could also be used in its relative valuation, which is a method of valuing NuGene International by comparing valuation metrics of similar companies.NuGene International is currently under evaluation in return on asset category among its peers.
NuGene Fundamentals
| Return On Asset | -9.44 | |||
| Profit Margin | (0.11) % | |||
| Operating Margin | (0.11) % | |||
| Current Valuation | 14.83 M | |||
| Shares Outstanding | 219 M | |||
| Shares Owned By Insiders | 5.85 % | |||
| Price To Earning | (0.03) X | |||
| Price To Sales | 9.65 X | |||
| Revenue | 1.47 M | |||
| Gross Profit | (209.4 K) | |||
| EBITDA | (9.03 M) | |||
| Net Income | (75.19 K) | |||
| Cash And Equivalents | 118.34 K | |||
| Total Debt | 2.8 M | |||
| Debt To Equity | 1.05 % | |||
| Current Ratio | 0.02 X | |||
| Book Value Per Share | 0.10 X | |||
| Cash Flow From Operations | (2 M) | |||
| Earnings Per Share | (0.29) X | |||
| Number Of Employees | 11 | |||
| Beta | 4.89 | |||
| Market Capitalization | 11.61 M | |||
| Total Asset | 585 K | |||
| Retained Earnings | (15.32 M) | |||
| Working Capital | (4.19 M) | |||
| Current Asset | 389 K | |||
| Current Liabilities | 4.58 M | |||
| Z Score | -89.9 |
About NuGene International Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NuGene International's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NuGene International using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NuGene International based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Livento Group, Inc. engages in the film and television production activities. Livento Group, Inc. was incorporated in 2013 and is based in New York, New York. Nugene International operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 11 people.
Pair Trading with NuGene International
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NuGene International position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NuGene International will appreciate offsetting losses from the drop in the long position's value.Moving against NuGene Pink Sheet
| 0.8 | BAC | Bank of America Aggressive Push | PairCorr |
| 0.76 | SYM | Symbotic | PairCorr |
| 0.74 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.73 | WMT | Walmart Aggressive Push | PairCorr |
| 0.69 | CVX | Chevron Corp Fiscal Year End 7th of February 2025 | PairCorr |
The ability to find closely correlated positions to NuGene International could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NuGene International when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NuGene International - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NuGene International to buy it.
The correlation of NuGene International is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NuGene International moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NuGene International moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NuGene International can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NuGene Pink Sheet
NuGene International financial ratios help investors to determine whether NuGene Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NuGene with respect to the benefits of owning NuGene International security.